http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2514022-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc7d171b38366dc4c4728e6f39b0fade
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
filingDate 2004-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f1f4bc7f797aa157ba0d85ca0f9d210
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa197734bde904eee66e506fb6847a9
publicationDate 2010-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2514022-C
titleOfInvention Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders
abstract The present invention relates to a method, preferable an oral method, for treating urinary disorders, such as unstable or overactive bladder, while minimizing the occurrences of dry mouth, dyspeptia and reduced stream of tears. The methods of the present invention comprise orally administering to a mammal, preferably a human, a pharmaceutically effective dose of an antimuscarinic agent, such as tolterodine, when needed, whereby a symptomatic relief of urgency and/or frequency is achieved.
priorityDate 2003-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420223184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426149486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410627548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414557382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9819382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452895039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12972417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119400

Total number of triples: 45.